S1 Corp (SONE) and Fundtech (FNDT) to Merge
Get Alerts SONE Hot Sheet
Join SI Premium – FREE
S1 Corporation (Nasdaq: SONE) and Fundtech Ltd. (Nasdaq: FNDT) entered into a definitive agreement to combine through a stock-for-stock merger.
Under the terms of the agreement, Fundtech shareholders will receive 2.72 shares of S1 common stock for each Fundtech ordinary share they own.
The value of the proposed transaction is worth $20.51 to Fundtech shareholders based on Friday's close, or a 4.7% premium to Fundtech's Friday close of $19.58.
S1 shareholders will own approximately 55 percent and Fundtech shareholders approximately 45 percent of the combined company.
S1 and Fundtech expect to complete the transaction in the fourth quarter of 2011.
Raymond James & Associates acted as financial advisor to S1 and Hogan Lovells US LLP and Zellermayer, Pelossof, Rosovsky, Tsafrir, Toledano & Co. provided legal counsel. Citi acted as financial advisor to Fundtech and Kirkland & Ellis LLP, Kramer Levin Naftalis & Frankel LLP and Meitar Liquornik Geva & Leshem Brandwein provided legal counsel.
Under the terms of the agreement, Fundtech shareholders will receive 2.72 shares of S1 common stock for each Fundtech ordinary share they own.
The value of the proposed transaction is worth $20.51 to Fundtech shareholders based on Friday's close, or a 4.7% premium to Fundtech's Friday close of $19.58.
S1 shareholders will own approximately 55 percent and Fundtech shareholders approximately 45 percent of the combined company.
S1 and Fundtech expect to complete the transaction in the fourth quarter of 2011.
Raymond James & Associates acted as financial advisor to S1 and Hogan Lovells US LLP and Zellermayer, Pelossof, Rosovsky, Tsafrir, Toledano & Co. provided legal counsel. Citi acted as financial advisor to Fundtech and Kirkland & Ellis LLP, Kramer Levin Naftalis & Frankel LLP and Meitar Liquornik Geva & Leshem Brandwein provided legal counsel.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $109 at Raymond James
- TDS drops bid for Array Digital Infrastructure minority shares
- S&P Weighs Multibillion-Dollar Spinout of Data Platform CapIQ - Bloomberg
Create E-mail Alert Related Categories
Mergers and AcquisitionsRelated Entities
Citi, Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share